NCT06117046View on ClinicalTrials.gov

The Cardio-protective Effect of Cardiomyopeptidin on Myocardial Injury in ICU Patients With Non-organic Heart Disease: a Prospective, Single-blind, Randomized Controlled Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

November 25, 2023

Study Completion Date

November 25, 2023

Conditions
Myocardial InjuryICU
Interventions
DRUG

Cardiopeptidin

Cardiopeptidin was administered intravenously once a day with cardiopeptidin for 3 days.The dosing regimen follows the recommended dosage of 1 mg/kg/day as outlined in the product manual, with doses calculated based on the ideal body weight.

DRUG

50 ml of normal saline intravenous infusion

50 ml of normal saline intravenous infusion

Trial Locations (1)

510515

Southern medical university Nanfang hospital, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER